Market Tracker

12/18 6:12am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

14.09
Data as of Dec 17
 +0.52 / +3.83%
Today’s Change
11.53
Today|||52-Week Range
18.48
+8.80%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close13.57
Today’s open13.59
Day’s range-- - --
Volume1,131,211
Average volume (3 months)1,579,537
Market cap$1.2B
Dividend yield--
Data as of 12/17/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-92.82%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book24.70

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.28+4.61%
PRAHPRA Health Sciences ...+0.44+1.86%
INCRINC Research Holding...+0.21+0.89%
NXTMNxStage Medical Inc+1.18+7.03%
Data as of 12/17/2014

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts